Effect of different formulation variables on some particle characteristics of poly (DL-lactide-co-glycolide) nanoparticles

Yakugaku Zasshi

Volumn 128, Issue 4, 2008, Pages 595-601

  Mondal, Nita ^a   Samanta, Arnab ^b   Pal, Tapan Kumar ^a   Ghosal, Saroj Kumar ^a  

^a JADAVPUR UNIVERSITY   (India)

^b BOSE INSTITUTE   (India)

Author keywords

Factorial design; Nanoparticles; Poly (DL lactide co glycolide); Response surface methodology

Indexed keywords

COPOLYMER; NANOPARTICLE; POLYGLACTIN;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; METHODOLOGY; NANOFABRICATION; PARTICLE SIZE;

CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; EMULSIONS; LACTIC ACID; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; SOLVENTS;

EID: 41849120776     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.128.595     Document Type: Article

References (27)

1. Julienne M. C., Alonso M. J., Benoit J. P., Drug Dev. Ind. Pharm., 18, 1063-1077 (1992).
2. Vandervoort J., Ludwig A., Int. J. Pharm., 238, 77-92 (2002).
3. Zhang L., Hu Y., Jiang X., Yang C., Lu W., Yang Y. H., J. Control. Rel., 96, 135-148 (2004).
4. Onishi H., Machida Y., Biol. Pharm. Bull., 26 (1), 116-119 (2003).
5. Yoo H. S., Park T. G., J. Control. Release, 70, 63-70 (2001).
6. Kim S. Y., Lee Y. M., Biomaterials, 22, 1697-1704 (2001).
7. Drummond D. C., Meyer O., Hoong K., Kirpotin D. B., Papahadjopoulos D., Pharmacol. Rev., 51(4), 691-744 (1999).
8. Brigger I., Dubernet C., Couvreur P., Adv. Drug. Deliv. Rev., 54, 631-651 (2002).
9. Dillen K., Vandervoort J., Mooter J. V., Verheyden L., Ludwig A., Int. J. Pharm., 275, 171-187 (2004).
10. Vandervoort J., Yoncheva K., Ludwig A., Chem. Pharm. Bull., 52, 1273-1279 (2004).
11. Fessi H., Puisieux F., Devissaguet J. P., Ammoury N., Betina S., Int. J. Pharm., 55, R1-R4 (1989).
12. Stetsko G., Drug Dev. Ind. Pharm., 12, 1109-1123 (1986).
13. Rizkalla N., Hildgen P., Drug Dev. Ind. Pharm., 31, 1019-1033 (2005).
14. Arulsudar N., Subramanian N., Murthy R. S. R., J. Pharm. Pharmaceut. Sci., 8(2), 243-258 (2005).
15. Vooren L. V., Spiegeleer B. D., J. Pharm. Pharmaceut. Sci., 5(2), 190-198 (2002).
16. Kincl M., Turk S., Vrecer F., Int. J. Pharm., 291, 39-49 (2005).
17. Vandervoort J., Ludwig A., Int. J. pharm., 236, 77-92 (2002).
18. Patel D. M., Patel N. M., Patel V. F., Bhatt D. A., AAPS PharmSciTech., 8(2), E1-E7 (2007).
19. Prakobvaitayakit M., Nimmannit U., AAPS PharmSciTech., 4, 1-9 (2003).
20. Mainardes R. M., Evangelista R. C., Int. J. Pharm., 290, 137-144 (2005).
21. Hussain H., Hasim S. F. S., Int. J. Miner. Process., 82, 195-202 (2007)
22. Derakhshandeh K., Erfan M., Dadashzadeh S., Eur. J. Pharm. Biopharm., 60, 34-41 (2006).
23. Sarkar A., Rano R., Misra K. K., Sinha I. N., Fuel Process. Technol., 86, 1221-1238 (2005).
24. Torrado J. J., Illum L., Davis S. S., Int. J. Pharm., 51, 85-93 (1989).
25. Barichello J. M, Morishita M., Takayama K., Nagai T., Drug Dev. Ind. Pharm., 25, 471-476 (1999).
26. Quintanar-Guerrero D., Allemann E., Fessi H., Doelker E., Drug Dev. Ind. Pharm., 24, 1113-1128 (1998).
27. Montgomery D. C., "Design and analysis of experiments," John Wiley & Sons, New York, 1996.